Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
STAR Protocols|August 31, 2023
Mouse intraductal modeling of primary ductal carcinoma in situStefan J Hutten, Fariba Behbod, Colinda L G J Scheele, et al.Plos One|January 24, 2017
Visualization of BRI1 and SERK3/BAK1 Nanoclusters in Arabidopsis RootsStefan J Hutten, Danny S Hamers, Marije Aan den Toorn, et al.Science Translational Medicine|March 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapiesStefan J Hutten, Xue Chao, Madelon Badoux, et al.The Journal of Pathology|May 23, 2024
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ductsStefan J Hutten, Hendrik A Messal, Esther H Lips, et al.Cancer Research|April 30, 2025
Large-Scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGF-β Signaling as a Key Regulator of Breast Cancer Morphology and AggressivenessCatrin Lutz, Xue Chao, Bim de Klein, et al.Breast Cancer Research : BCR|February 19, 2024
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancersFrançoise Derouane, Manon Desgres, Camilla Moroni, et al.Nature|September 4, 2024
Mechanisms that clear mutations drive field cancerization in mammary tissueMarta Ciwinska, Hendrik A Messal, Hristina R Hristova, et al.Cancer Research|October 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister StateYoussef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba, et al.Cancer Cell|April 28, 2023
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progressionStefan J Hutten, Roebi de Bruijn, Catrin Lutz, et al.Pageof 1